174 related articles for article (PubMed ID: 8394141)
21. X-linked chronic granulomatous disease: correction of NADPH oxidase defect by retrovirus-mediated expression of gp91-phox.
Porter CD; Parkar MH; Levinsky RJ; Collins MK; Kinnon C
Blood; 1993 Oct; 82(7):2196-202. PubMed ID: 8400270
[TBL] [Abstract][Full Text] [Related]
22. Activation of the O2(-)-generating NADPH oxidase in a semi-recombinant cell-free system. Assessment of the function of Rac in the activation process.
Fuchs A; Dagher MC; Jouan A; Vignais PV
Eur J Biochem; 1994 Dec; 226(2):587-95. PubMed ID: 8001573
[TBL] [Abstract][Full Text] [Related]
23. Production of myeloid cell cytosols functionally and immunochemically deficient in the 47 kDa or 67 kDa NADPH oxidase cytosolic factors.
Levy R; Malech HL; Rotrosen D
Biochem Biophys Res Commun; 1990 Aug; 170(3):1114-20. PubMed ID: 2167670
[TBL] [Abstract][Full Text] [Related]
24. Chronic granulomatous disease: towards gene therapy.
Thrasher A; Segal A; Casimir C
Immunodeficiency; 1993; 4(1-4):327-33. PubMed ID: 8167728
[TBL] [Abstract][Full Text] [Related]
25. A phosphoprotein of Mr 47,000, defective in autosomal chronic granulomatous disease, copurifies with one of two soluble components required for NADPH:O2 oxidoreductase activity in human neutrophils.
Bolscher BG; van Zwieten R; Kramer IM; Weening RS; Verhoeven AJ; Roos D
J Clin Invest; 1989 Mar; 83(3):757-63. PubMed ID: 2537848
[TBL] [Abstract][Full Text] [Related]
26. NADPH-binding component of the respiratory burst oxidase system: studies using neutrophil membranes from patients with chronic granulomatous disease lacking the beta-subunit of cytochrome b558.
Tsunawaki S; Mizunari H; Namiki H; Kuratsuji T
J Exp Med; 1994 Jan; 179(1):291-7. PubMed ID: 8270871
[TBL] [Abstract][Full Text] [Related]
27. Phenylarsine oxide as an inhibitor of the activation of the neutrophil NADPH oxidase--identification of the beta subunit of the flavocytochrome b component of the NADPH oxidase as a target site for phenylarsine oxide by photoaffinity labeling and photoinactivation.
Doussiere J; Poinas A; Blais C; Vignais PV
Eur J Biochem; 1998 Feb; 251(3):649-58. PubMed ID: 9490037
[TBL] [Abstract][Full Text] [Related]
28. Neutrophil nicotinamide adenine dinucleotide phosphate oxidase assembly. Translocation of p47-phox and p67-phox requires interaction between p47-phox and cytochrome b558.
Heyworth PG; Curnutte JT; Nauseef WM; Volpp BD; Pearson DW; Rosen H; Clark RA
J Clin Invest; 1991 Jan; 87(1):352-6. PubMed ID: 1985107
[TBL] [Abstract][Full Text] [Related]
29. 156Pro-->Gln substitution in the light chain of cytochrome b558 of the human NADPH oxidase (p22-phox) leads to defective translocation of the cytosolic proteins p47-phox and p67-phox.
Leusen JH; Bolscher BG; Hilarius PM; Weening RS; Kaulfersch W; Seger RA; Roos D; Verhoeven AJ
J Exp Med; 1994 Dec; 180(6):2329-34. PubMed ID: 7964505
[TBL] [Abstract][Full Text] [Related]
30. Despite structural similarities between gp91phox and FRE1, flavocytochrome b558 does not mediate iron uptake by myeloid cells.
DeLeo FR; Olakanmi O; Rasmussen GT; Lewis TS; McCormick SJ; Nauseef WM; Britigan BE
J Lab Clin Med; 1999 Sep; 134(3):275-82. PubMed ID: 10482313
[TBL] [Abstract][Full Text] [Related]
31. Prolonged recombinant interferon-gamma therapy in chronic granulomatous disease: evidence against enhanced neutrophil oxidase activity.
Woodman RC; Erickson RW; Rae J; Jaffe HS; Curnutte JT
Blood; 1992 Mar; 79(6):1558-62. PubMed ID: 1312372
[TBL] [Abstract][Full Text] [Related]
32. CD34+ peripheral blood progenitors as a target for genetic correction of the two flavocytochrome b558 defective forms of chronic granulomatous disease.
Li F; Linton GF; Sekhsaria S; Whiting-Theobald N; Katkin JP; Gallin JI; Malech HL
Blood; 1994 Jul; 84(1):53-8. PubMed ID: 7517218
[TBL] [Abstract][Full Text] [Related]
33. Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two cytosolic components of the NADPH oxidase system.
Clark RA; Malech HL; Gallin JI; Nunoi H; Volpp BD; Pearson DW; Nauseef WM; Curnutte JT
N Engl J Med; 1989 Sep; 321(10):647-52. PubMed ID: 2770793
[TBL] [Abstract][Full Text] [Related]
34. O2- production by B lymphocytes lacking the respiratory burst oxidase subunit p47phox after transfection with an expression vector containing a p47phox cDNA.
Chanock SJ; Faust LR; Barrett D; Bizal C; Maly FE; Newburger PE; Ruedi JM; Smith RM; Babior BM
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10174-7. PubMed ID: 1332032
[TBL] [Abstract][Full Text] [Related]
35. Partial reconstitution of the respiratory burst oxidase in lymphoblastoid B cell lines lacking p67-phox after transfection with an expression vector containing wild-type and mutant p67 -phox cDNAs: Deletions of the carboxy and amino terminal residues of p67-phox are not required for activity.
Chanock SJ; Faust LR; Barrett D; Christensen B; Newburger PE; Babior BM
Exp Hematol; 1996 Mar; 24(4):531-6. PubMed ID: 8608803
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the NADPH oxidase components during differentiation of HL-60 cells to eosinophilic lineage.
Miyamoto D; Someya A; Nunoi H; Nagaoka I; Yamashita T
Biochim Biophys Acta; 1994 Oct; 1224(1):11-6. PubMed ID: 7948035
[TBL] [Abstract][Full Text] [Related]
37. Two cytosolic neutrophil oxidase components absent in autosomal chronic granulomatous disease.
Volpp BD; Nauseef WM; Clark RA
Science; 1988 Dec; 242(4883):1295-7. PubMed ID: 2848318
[TBL] [Abstract][Full Text] [Related]
38. Cytosolic components of the respiratory burst oxidase: resolution of four components, two of which are missing in complementing types of chronic granulomatous disease.
Curnutte JT; Scott PJ; Mayo LA
Proc Natl Acad Sci U S A; 1989 Feb; 86(3):825-9. PubMed ID: 2915980
[TBL] [Abstract][Full Text] [Related]
39. Drug-selected complete restoration of superoxide generation in Epstein-Barr virus-transformed B cells from p47phox-deficient chronic granulomatous disease patients by using a bicistronic retrovirus vector encoding a human multi-drug resistance gene (MDR1) and the p47phox gene.
Iwata M; Nunoi H; Matsuda I; Kanegasaki S; Tsuruo T; Sugimoto Y
Hum Genet; 1998 Oct; 103(4):419-23. PubMed ID: 9856484
[TBL] [Abstract][Full Text] [Related]
40. Chronic granulomatous disease due to a defect in the cytosolic factor required for nicotinamide adenine dinucleotide phosphate oxidase activation.
Curnutte JT; Berkow RL; Roberts RL; Shurin SB; Scott PJ
J Clin Invest; 1988 Feb; 81(2):606-10. PubMed ID: 3339133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
